EMCURE PHARMACEUTICALS LIMITED BOM

EMCURE PHARMACEUTICALS LIMITED is a Manufacturer.

Company Introduction:

Emcure Pharmaceuticals Limited is a leading Indian pharmaceutical company headquartered in Pune, India. Established in 1981, the company is engaged in the development, manufacturing, and marketing of a broad range of pharmaceutical products across various therapeutic areas. Emcure has a strong focus on research and development, operating multiple state-of-the-art manufacturing facilities that adhere to international regulatory standards. Its product portfolio includes both branded and generic formulations, as well as biopharmaceuticals. The company has a significant presence in India and exports its products to numerous countries globally, establishing itself as a key player in the international pharmaceutical market. Emcure Pharmaceuticals Limited is listed on the Bombay Stock Exchange (BOM), reflecting its public status.

Emcure Pharmaceuticals Limited manufactures and sells a diverse range of pharmaceutical products across various therapeutic segments. Their product portfolio primarily includes:

- Gynaecology: Products for women's health, including iron supplements, prenatal vitamins, and treatments for various gynaecological conditions.

- Oncology: A broad range of anti-cancer drugs and supportive care medications.

- Cardiology: Medications for cardiovascular health, including anti-hypertensives and anti-platelet drugs.

- Nephrology: Products for kidney-related conditions.

- Anti-infectives: Antibiotics, antifungals, and antivirals.

- Pain and Inflammation: Analgesics and anti-inflammatory drugs.

- Neurology: Medications for neurological disorders.

- Gastroenterology: Products for digestive health.

- Vitamins and Minerals: Nutritional supplements.

- Dermatology: Products for skin conditions.

- Respiratory: Medications for respiratory ailments.

They produce a wide array of formulations including tablets, capsules, injections, oral liquids, and topical preparations, encompassing both branded generics and active pharmaceutical ingredients (APIs) for various therapeutic applications.